Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cervical Cytology DNA Methylation for Endometrial Cancer Screening
Sponsor: Lei Li
Summary
This study intends to conduct the "Real-world Study on Cervical Cytology Methylation Testing for Endometrial Cancer Screening" project through a multi-center real-world research approach. Led by Peking Union Medical College Hospital, at least 10 institutions will participate in the study. The goal is to complete the enrollment of at least 30 million real-world samples. Focusing on the changes in DNA methylation levels in cervical exfoliated cells as the research entry point, this study aims to provide new ideas and theoretical basis for preventing and treating endometrial cancer by targeting the CDO1/CELF4 double gene methylation. The expectation is to achieve the clinical application of a more optimal endometrial cancer screening protocol, improve the current shortcomings of endometrial cancer screening, make endometrial cancer screening more accurate, effectively reduce the incidence of endometrial cancer, and avoid excessive medical treatment.
Official title: A Real-world Study on the Use of Cervical Cytology Methylation Testing for the Screening of Endometrial Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30000
Start Date
2025-12-12
Completion Date
2027-12-01
Last Updated
2026-10-15
Healthy Volunteers
No
Interventions
CDO1 and CELF4 gene methylation
CDO1m and CELF4m for cervical cancer screening
Locations (1)
Peking Union Medical College Hospital
Beijing, China